Annual Cash & Cash Equivalents
$6.57 M
+$2.38 M+57.04%
December 31, 2023
Summary
- As of February 12, 2025, BIOL annual cash & cash equivalents is $6.57 million, with the most recent change of +$2.38 million (+57.04%) on December 31, 2023.
- During the last 3 years, BIOL annual cash & cash equivalents has fallen by -$11.00 million (-62.62%).
Performance
BIOL Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Quarterly Cash And Cash Equivalents
$3.44 M
-$1.83 M-34.67%
September 30, 2024
Summary
- As of February 12, 2025, BIOL quarterly cash and cash equivalents is $3.44 million, with the most recent change of -$1.83 million (-34.67%) on September 30, 2024.
- Over the past year, BIOL quarterly cash and cash equivalents has dropped by -$4.37 million (-55.90%).
Performance
BIOL Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Cash And Cash Equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
BIOL Cash And Cash Equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +57.0% | -55.9% |
| 3 y3 years | -62.6% | -55.9% |
| 5 y5 years | -18.4% | -55.9% |
BIOL Cash And Cash Equivalents Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -78.1% | -36.3% | -88.5% | at low |
| 5 y | 5-year | -78.1% | -36.3% | -91.6% | -56.1% |
| alltime | all time | -79.2% | -97.0% | -93.1% | -97.1% |
BIOLASE Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $3.44 M(-34.7%) |
| Jun 2024 | - | $5.27 M(-17.5%) |
| Mar 2024 | - | $6.39 M(-2.6%) |
| Dec 2023 | $6.57 M(+57.0%) | $6.57 M(-15.9%) |
| Sep 2023 | - | $7.81 M(+12.7%) |
| Jun 2023 | - | $6.93 M(+6.1%) |
| Mar 2023 | - | $6.53 M(+56.2%) |
| Dec 2022 | $4.18 M(-86.1%) | $4.18 M(-58.0%) |
| Sep 2022 | - | $9.96 M(-49.1%) |
| Jun 2022 | - | $19.55 M(-9.5%) |
| Mar 2022 | - | $21.61 M(-27.9%) |
| Dec 2021 | $29.97 M(+70.6%) | $29.97 M(-10.2%) |
| Sep 2021 | - | $33.38 M(-10.0%) |
| Jun 2021 | - | $37.08 M(-9.2%) |
| Mar 2021 | - | $40.84 M(+132.5%) |
| Dec 2020 | $17.56 M(+203.4%) | $17.56 M(-6.8%) |
| Sep 2020 | - | $18.85 M(+246.6%) |
| Jun 2020 | - | $5.44 M(+259.8%) |
| Mar 2020 | - | $1.51 M(-73.9%) |
| Dec 2019 | $5.79 M(-28.0%) | $5.79 M(+176.9%) |
| Sep 2019 | - | $2.09 M(-43.8%) |
| Jun 2019 | - | $3.72 M(+25.8%) |
| Mar 2019 | - | $2.96 M(-63.3%) |
| Dec 2018 | $8.04 M(-30.9%) | $8.04 M(+259.4%) |
| Sep 2018 | - | $2.24 M(-22.7%) |
| Jun 2018 | - | $2.90 M(-65.9%) |
| Mar 2018 | - | $8.48 M(-27.2%) |
| Dec 2017 | $11.64 M(+30.5%) | $11.64 M(+161.5%) |
| Sep 2017 | - | $4.45 M(-43.7%) |
| Jun 2017 | - | $7.92 M(+121.4%) |
| Mar 2017 | - | $3.58 M(-59.9%) |
| Dec 2016 | $8.92 M(-23.7%) | $8.92 M(-29.5%) |
| Sep 2016 | - | $12.65 M(+159.4%) |
| Jun 2016 | - | $4.88 M(-26.4%) |
| Mar 2016 | - | $6.63 M(-43.4%) |
| Dec 2015 | $11.70 M(-62.9%) | $11.70 M(-23.0%) |
| Sep 2015 | - | $15.19 M(-23.7%) |
| Jun 2015 | - | $19.92 M(-16.1%) |
| Mar 2015 | - | $23.74 M(-24.8%) |
| Dec 2014 | $31.56 M(+2091.7%) | $31.56 M(+1043.9%) |
| Sep 2014 | - | $2.76 M(+32.5%) |
| Jun 2014 | - | $2.08 M(+13.5%) |
| Mar 2014 | - | $1.83 M(+27.4%) |
| Dec 2013 | $1.44 M(-43.4%) | $1.44 M(-65.3%) |
| Sep 2013 | - | $4.15 M(+97.6%) |
| Jun 2013 | - | $2.10 M(+71.0%) |
| Mar 2013 | - | $1.23 M(-51.7%) |
| Dec 2012 | $2.54 M(-23.1%) | $2.54 M(+96.4%) |
| Sep 2012 | - | $1.29 M(-19.4%) |
| Jun 2012 | - | $1.61 M(-42.0%) |
| Mar 2012 | - | $2.77 M(-16.2%) |
| Dec 2011 | $3.31 M(+95.2%) | $3.31 M(-42.6%) |
| Sep 2011 | - | $5.76 M(-43.2%) |
| Jun 2011 | - | $10.13 M(+521.0%) |
| Mar 2011 | - | $1.63 M(-3.7%) |
| Dec 2010 | $1.69 M(-43.1%) | $1.69 M(-23.9%) |
| Sep 2010 | - | $2.23 M(-23.1%) |
| Jun 2010 | - | $2.90 M(-15.5%) |
| Mar 2010 | - | $3.43 M(+15.2%) |
| Dec 2009 | $2.98 M(-73.5%) | $2.98 M(-23.3%) |
| Sep 2009 | - | $3.88 M(+11.2%) |
| Jun 2009 | - | $3.49 M(+92.7%) |
| Mar 2009 | - | $1.81 M(-83.9%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2008 | $11.23 M(-22.9%) | $11.23 M(-27.4%) |
| Sep 2008 | - | $15.48 M(+6.7%) |
| Jun 2008 | - | $14.51 M(+4.5%) |
| Mar 2008 | - | $13.88 M(-4.7%) |
| Dec 2007 | $14.57 M(-0.7%) | $14.57 M(+22.5%) |
| Sep 2007 | - | $11.89 M(-0.7%) |
| Jun 2007 | - | $11.97 M(-6.4%) |
| Mar 2007 | - | $12.79 M(-12.9%) |
| Dec 2006 | $14.68 M(+77.4%) | $14.68 M(+155.4%) |
| Sep 2006 | - | $5.75 M(-25.6%) |
| Jun 2006 | - | $7.72 M(+29.2%) |
| Mar 2006 | - | $5.97 M(-27.8%) |
| Dec 2005 | $8.27 M(+34.7%) | $8.27 M(+4.9%) |
| Sep 2005 | - | $7.88 M(-28.2%) |
| Jun 2005 | - | $10.98 M(+272.6%) |
| Mar 2005 | - | $2.95 M(-52.0%) |
| Dec 2004 | $6.14 M(-44.7%) | $6.14 M(+53.8%) |
| Sep 2004 | - | $3.99 M(-25.7%) |
| Jun 2004 | - | $5.37 M(-89.3%) |
| Mar 2004 | - | $50.09 M(+350.9%) |
| Dec 2003 | $11.11 M(+182.0%) | $11.11 M(+81.5%) |
| Sep 2003 | - | $6.12 M(-7.9%) |
| Jun 2003 | - | $6.65 M(+14.4%) |
| Mar 2003 | - | $5.81 M(+47.5%) |
| Dec 2002 | $3.94 M(+47.6%) | $3.94 M(+34.9%) |
| Sep 2002 | - | $2.92 M(+13.7%) |
| Jun 2002 | - | $2.57 M(+4.0%) |
| Mar 2002 | - | $2.47 M(-7.5%) |
| Dec 2001 | $2.67 M(+33.4%) | $2.67 M(+11.3%) |
| Sep 2001 | - | $2.40 M(-31.6%) |
| Jun 2001 | - | $3.51 M(+38.4%) |
| Mar 2001 | - | $2.53 M(+26.6%) |
| Dec 2000 | $2.00 M(+69.5%) | $2.00 M(+52.1%) |
| Sep 2000 | - | $1.32 M(-61.5%) |
| Jun 2000 | - | $3.42 M(-18.1%) |
| Mar 2000 | - | $4.18 M(+253.9%) |
| Dec 1999 | $1.18 M(+195.3%) | $1.18 M(-15.6%) |
| Sep 1999 | - | $1.40 M(-22.2%) |
| Jun 1999 | - | $1.80 M(-48.6%) |
| Mar 1999 | - | $3.50 M(+775.0%) |
| Dec 1998 | $400.00 K(+100.0%) | $400.00 K(+100.0%) |
| Sep 1998 | - | $200.00 K(-75.0%) |
| Jun 1998 | - | $800.00 K(+700.0%) |
| Mar 1998 | - | $100.00 K(-50.0%) |
| Dec 1997 | $200.00 K(-33.3%) | $200.00 K(-33.3%) |
| Sep 1997 | - | $300.00 K(0.0%) |
| Jun 1997 | - | $300.00 K(-40.0%) |
| Mar 1997 | - | $500.00 K(+66.7%) |
| Dec 1996 | $300.00 K(-81.3%) | $300.00 K(+200.0%) |
| Sep 1996 | - | $100.00 K(-83.3%) |
| Jun 1996 | - | $600.00 K(-45.5%) |
| Mar 1996 | - | $1.10 M(-31.3%) |
| Dec 1995 | $1.60 M(+33.3%) | $1.60 M(-11.1%) |
| Sep 1995 | - | $1.80 M(+63.6%) |
| Jun 1995 | - | $1.10 M(+175.0%) |
| Mar 1995 | - | $400.00 K(-66.7%) |
| Dec 1994 | $1.20 M(-40.0%) | $1.20 M(-29.4%) |
| Sep 1994 | - | $1.70 M(+240.0%) |
| Jun 1994 | - | $500.00 K(-75.0%) |
| Dec 1993 | $2.00 M(+53.8%) | $2.00 M(+1900.0%) |
| Mar 1993 | - | $100.00 K(-92.3%) |
| Dec 1992 | $1.30 M | $1.30 M(+333.3%) |
| Sep 1992 | - | $300.00 K(-76.9%) |
| Jun 1992 | - | $1.30 M |
FAQ
- What is BIOLASE annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for BIOLASE?
- What is BIOLASE annual cash & cash equivalents year-on-year change?
- What is BIOLASE quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for BIOLASE?
- What is BIOLASE quarterly cash and cash equivalents year-on-year change?
What is BIOLASE annual cash & cash equivalents?
The current annual cash & cash equivalents of BIOL is $6.57 M
What is the all time high annual cash & cash equivalents for BIOLASE?
BIOLASE all-time high annual cash & cash equivalents is $31.56 M
What is BIOLASE annual cash & cash equivalents year-on-year change?
Over the past year, BIOL annual cash & cash equivalents has changed by +$2.38 M (+57.04%)
What is BIOLASE quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of BIOL is $3.44 M
What is the all time high quarterly cash and cash equivalents for BIOLASE?
BIOLASE all-time high quarterly cash and cash equivalents is $50.09 M
What is BIOLASE quarterly cash and cash equivalents year-on-year change?
Over the past year, BIOL quarterly cash and cash equivalents has changed by -$4.37 M (-55.90%)